Mono Pharmacare Limited

₹10.00As of Sun 8 Nov 2026, 12:00 UTC
NSE:MONOPHARMAHealthcare
Country India
PE (Fwd) •••
TSR 3Y CAGR (31.83%)
Div yield —
ROE 2.32%
Medical Distribution
Beta (5Y) (0.36)
PE TTM 24.39
TSR TTM (50.00%)
Mkt cap ₹176.7M
ROIC 3.40%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹11
10.83%
(55.70%)
Hold 12|3|1|5|7
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.11
0.11
0.11
0.11
11.66%
1.53%
3.67%
(2.30%)
Revenue₹M
16.74
17.12
17.39
16.88
8.38%
4.78%
4.70%
0.13%
Peers (US$1.881M)
Cap (US$)
PE
34.97M
31.12x
5.872M
98.29x
Capital
TTM
5Y
10Y
Leveragex
1.142
(0.052)
(0.050)
EBIT/Intx
0.191
0.587
0.607
Own earn%
128.91
112.68
97.83
Sh yield%
21.89
24.92
27.24
Owners
Insiders/Inst%
0.54
66.71
Short interest%
1.01
SBC / revenue%
5.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
18–27
$1 testx
0.0
Incr. ROIC%
16